<?xml version="1.0" encoding="utf-8"?>
<DATASETS>
	<DATASET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" alias="PRAD-CA_PCAWG_WGS_BWA" center_name="ICGC" broker_name="EGA" accession="EGAD00001002128">
		<TITLE>ICGC PCAWG Dataset: PRAD-CA_PCAWG_WGS_BWA</TITLE>
		<DESCRIPTION>ICGC PCAWG Dataset for WGS BAM aligned using BWA MEM. Project: PRAD-CA.</DESCRIPTION>
		<ANALYSIS_REF accession="EGAZ00001223232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223241"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225252"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225260"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225247"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225316"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225314"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223176"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225262"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225319"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225295"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225271"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225269"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223261"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223250"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225302"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225296"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225278"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225270"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225245"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225220"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223275"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225272"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225242"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225241"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223172"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225305"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225310"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223196"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223256"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223200"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223268"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225261"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225279"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223182"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223270"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225283"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225323"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225263"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225255"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223253"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225303"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223245"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223186"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225311"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223246"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225312"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225265"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225282"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223254"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223221"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225322"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225211"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225254"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225199"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225232"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225191"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223210"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225292"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225300"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225259"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223267"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225275"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225267"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225243"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223239"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223255"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223224"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225244"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225304"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223223"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225236"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223226"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223243"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225289"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223173"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223184"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225258"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223260"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223266"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223269"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223175"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225248"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223259"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225206"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225276"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225315"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225198"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225291"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223187"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223193"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225268"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225293"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225306"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223188"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225238"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225225"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225297"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225294"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223257"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223231"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225307"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225288"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225318"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225277"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223265"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223177"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225251"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223247"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225208"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223217"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225216"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225195"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225180"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223181"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223229"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225230"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223234"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225212"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225286"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223237"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225250"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225313"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225214"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225285"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225284"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223195"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225219"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225299"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225321"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223222"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223194"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223179"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223189"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225190"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225246"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225281"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223183"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223248"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225203"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223251"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225209"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223215"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223249"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225240"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223252"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223272"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225207"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225185"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225290"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225298"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223174"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225253"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225273"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225280"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223218"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223264"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223242"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225213"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225192"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223204"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223271"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225256"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225308"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223274"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223201"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225235"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223233"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223205"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225309"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223258"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225202"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223263"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223240"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223273"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225274"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225257"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225264"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225287"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225249"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225301"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225266"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223197"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225227"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223178"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001223244"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225228"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225317"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225320"></ANALYSIS_REF>
		<ANALYSIS_REF accession="EGAZ00001225196"></ANALYSIS_REF>
		<POLICY_REF accession="EGAP00001000011" refname="ICGC Data Access Agreements" refcenter="ICGC">
			<IDENTIFIERS>
				<PRIMARY_ID>EGAP00001000011</PRIMARY_ID>
				<SUBMITTER_ID namespace="ICGC">ICGC Data Access Agreements</SUBMITTER_ID>
			</IDENTIFIERS>
		</POLICY_REF>
		<DATASET_LINKS>
			<DATASET_LINK>
				<URL_LINK>
					<LABEL>ICGC Data Portal</LABEL>
					<URL>http://dcc.icgc.org</URL>
				</URL_LINK>
			</DATASET_LINK>
		</DATASET_LINKS>
	</DATASET>
</DATASETS>